Effects of TRH therapy on the prism adaptation task in patients with spinocerebellar degeneration.
Objective: To reveal effects of TRH therapy on the prism adaptation task in patients with spinocerebellar degeneration (SCD). Background: TRH [Thyrotropin releasing hormone (protirelin tartrate)]…Voice Cepstral Analysis in Adductor-Type Spasmodic Dysphonia
Objective: To investigate differences in voice parameters between patients affected by adductor-type spasmodic dysphonia (ASD) and Healthy subjects (HS). Background: Adductor-type spasmodic dysphonia (ASD) is…Network for parallel gamma synchronizations during upper limb movement
Objective: Our aim was to identify the sources of parallel gamma synchronizations (GS) and analyze the direction of information flow in their network, at the…Mild cognitive impairment in newly diagnosed Parkinson’s disease: a three year follow up
Objective: To evaluate the stability of mild cognitive impairment in Parkinson’s disease (PD-MCI) over time to determine its clinical utility as a marker of disease.…Validation of a performance-based assessment of functional ability related to cognition in Parkinson’s disease
Objective: Validate the University of California San Diego Performance-Based Skills Assessment (UPSA) in Parkinson's disease (PD) Background: Diagnostic criteria for PD dementia (PDD) require significant…Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns
Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…Tau predicts cognitive impairment in a prospective longitudinal CSF study in Parkinson’s Disease
Objective: We hypothesize that CSF profiles of Aβ and Tau (total and phosphorylated) are associated with clinical subtypes and disease progression. Background: Parkinson’s disease (PD)…Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage
Objective: We examined the effect of dopaminergic medication on executive function in 24 drug-naïve PD patients (de novo group) and in 21 PD patients on…Development and validation of an alternative version of the Parkinson’s Disease-Cognitive Rating Scale
Objective: To develop and validate an alternative form of the PD-CRS (PD-CRS/AF) with the objective of providing a reliable and fully equivalent method of reassessment…Cognitive data in the Parkinson’s Progression Markers Initiative: Comparison of normative data approaches
Objective: It is important to understand underlying psychometric properties of the cognitive tests included in the Parkinson’s Progression Markers Initiative (PPMI) dataset to interpret the…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.